Anonymous
Guest
Anonymous
Guest
I interviewed for one of these jobs but never heard back so in curious how the launch is going so far?
I interviewed for one of these jobs but never heard back so in curious how the launch is going so far?
I interviewed for one of these jobs but never heard back so in curious how the launch is going so far?
Why would you want samples since there are no lab tests which can monitor the therapeutic levels of the drug after administration? So for instance you can't send a patient home with Zontivity samples and have them come back to measure their INR to see if it is in the therapeutic range, or to see if the drug is working. Standard coagulation tests are not effective to measure whether or not Zontivity is working, you can only monitor the patient for adverse bleeding events resulting from using the drug, which could happen anytime (days, weeks, years) during the course of therapy, not just in the tiny sample window timeframe. In other words, you could send the patient home on samples, and just because they don't experience a major bleeding event when the samples run out, that doesn't mean they won't experience a major bleeding event next month, or later. That's not the same issue as sending a patient home with a sample of Januvia and later measuring their A1C levels to gauge effectiveness or sending a patient home with an antibiotic and waiting to see if they get a rash. With this drug, you would be sending them home with a sample and waiting to see if they start bleeding from their ears, eyes, nose or suffer a seizure indicating an intracranial hemorrhage. In the clinical trials, Zontivity increased GUSTO moderate or severe bleeding by 55%!
It's going ok but the label is restrictive. It's not going to be a blockbuster.
Zontivity was launched, who knew???
How much market share does it have so far?
How much market share does it have so far?
Any thoughts on how bad the cuts will be for the group on December 1?
We should know a lot more after the IMPROVE IT study results come out.